In This Store
Hubei Honch Pharmecutical Co.,Ltd develops and comercializes inovative APIs of human anti-tumor and veterinary anthelmintic.
Located in Qichun county, the city of Chinese traditional medicine, Hubei Honch Pharmaceutical Co., Ltd is specialized in developing and manufacturing innovative APIs from 2007.
The company’s products portfolio comprises Anti-tumor APIs, including Vinorlbine Tartrate, Vinblastine Sulfate, Vincristine Sulfate, Mitomycin, Epothilone, etc, and Veterinary Anthelmintic, including Milbemycin Oxime, Spinosad, Selamectin, Tulathromycin, etc. The production lines are compoesed with fermentation and synthetic workshops. Each product and each product line is required to comply to cGMP and other overseas regulations. Some of our products have obtained the cGMP certificates / DMF / VMF and CEP already, and more are in the process of certification.
With high quality and considerate services, the APIs from Honch have gained good reputation among the clients all over the world. Honch is devoted to bring more and better APIs to the world, helping patients to have better healthy life.
Total Revenue: |
$6 Million |
Employees: |
>100 |
Patents: |
5 |
Exporting: |
Over 25 countries |
Focus: |
Anti-tumor; Anti-parasitic, Animal Heath |
Strategy: |
|
Year of Establishment: 2007
Total Assets(USD): choose not to disclose
Total Number of Staff: 100 to 149
Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Production capacity,Large Product Line,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: